Merits and culprits of immunotherapies for neurological diseases in times of COVID-19

Immunosuppression and immunomodulation are valuable therapeutic approaches for managing neuroimmunological diseases. In times of the Coronavirus disease 2019 (COVID-19) pandemic, clinicians must deal with the question of whether immunotherapy should currently be initiated or discontinued in neurolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Pawlitzki, Marc, Zettl, Uwe K., Ruck, Tobias, Rolfes, Leoni, Hartung, Hans-Peter, Meuth, Sven G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286830/
https://www.ncbi.nlm.nih.gov/pubmed/32535547
http://dx.doi.org/10.1016/j.ebiom.2020.102822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286830/
https://www.ncbi.nlm.nih.gov/pubmed/32535547
http://dx.doi.org/10.1016/j.ebiom.2020.102822

Ejemplares similares